Magnetic resonance disease severity scale (MRDSS) for patients with multiple sclerosis: A longitudinal study

Journal of the Neurological Sciences

Volumn 315, Issue 1-2, 2012, Pages 49-54

  Moodie, Jennifer ^a   Healy, Brian C ^b   Buckle, Guy J ^b   Gauthier, Susan A ^c   Glanz, Bonnie I ^b   Arora, Ashish ^b   Ceccarelli, Antonia ^b   Tauhid, Shahamat ^b   Han, Xue Mei ^b   Venkataraman, Arun ^b   Chitnis, Tanuja ^b   Khoury, Samia J ^b   Guttmann, Charles R G ^d   Weiner, Howard L ^b   Neema, Mohit ^b   Bakshi, Rohit ^b  

^a UNIVERSITY OF MASSACHUSETTS BOSTON   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Brain atrophy; Measurement scales; MRI; Multiple sclerosis; Neurologic disability; T1 hypointense lesions; T2 hyperintense lesions

Indexed keywords

ADULT; ARTICLE; DISEASE COURSE; DISEASE DURATION; FEMALE; FOLLOW UP; HUMAN; LONGITUDINAL STUDY; MAGNETIC RESONANCE DISEASE SEVERITY SCALE; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; PRIORITY JOURNAL; RATING SCALE; RELAPSE;

ADULT; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 84857996190     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2011.11.040     Document Type: Article

References (23)

1. Zivadinov R, Leist TP. Clinical-MRI correlations inmultiple sclerosis. J Neuroimaging 2005;15:10S-21S.
2. Wolinsky JS, Narayana PA, Noseworthy JH, Lublin FD, Whitaker JN, Linde A, et al. Linomide in relapsing and secondary progressive MS: Part II: MRI results. MRI Analysis Center of the University of Texas - Houston, Health Science Center, and the North American Linomide Investigators. Neurology 2000;54:1734-41.
3. Mainero C, De Stefano N, Iannucci G, Sormani MP, Guidi L, Federico A, et al. Correlates of MS disability assessed in vivo using aggregates of MR quantities. Neurology 2001;56:1331-4. (Pubitemid 32455293)
4. Wolinsky JS, Narayana PA, Johnson KP. Multiple Sclerosis Study Group and the MRI Analysis Center. United States open-label glatiramer acetate extension trial for relapsing multiple sclerosis: MRI and clinical correlates. Mult Scler 2001;7:33-41. (Pubitemid 32396577)
5. Sriram S, Yao SY, Stratton C, Moses H, Narayana PA, Wolinsky JS. Pilot study to examine the effect of antibiotic therapy on MRI outcomes in PRMS. J Neurol Sci 2005;20:1-5.
6. Poonawalla AH, Datta S, Juneja V, Nelson F, Wolinsky JS, Cutter G, et al. Composite MRI scores improve correlation with EDSS in multiple sclerosis. Mult Scler 2010;16:1117-25.
7. Bakshi R, Neema M, Healy BC, Liptak Z, Betensky RA, Buckle GJ, et al. Predicting clinical progression in multiple sclerosis with the magnetic resonance disease severity scale. Arch Neurol 2008;65:1449-53.
8. Gauthier SA, Glanz BI, Mandel M, Weiner HL. A model for the comprehensive investigation of a chronic autoimmune disease: the multiple sclerosis CLIMB study. Autoimmun Rev 2006;5:532-6. (Pubitemid 44488756)
9. Kurtzke JF. Rating neurologic impairment inmultiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444-52. (Pubitemid 14237132)
10. Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol 2005;58:840-6. (Pubitemid 41746873)
11. Lublin FD, Reingold SC, for the National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Defining the clinical course of multiple sclerosis: results of an international survey. Neurology 1996;46:907-11. (Pubitemid 26134623)
12. Wei X, Warfield S, Zou KH, Wu Y, Li X, Guimond A, et al. Quantitative analysis of MRI signal abnormalities of brain white matter with high reproducibility and accuracy. J Magn Reson Imaging 2002;15:203-9. (Pubitemid 34112912)
13. Pelletier D, Garrison K, Henry R. Measurement of whole-brain atrophy in multiple sclerosis. J Neuroimaging 2004;14:11S-9S. (Pubitemid 38781407)
14. Bermel RA, Sharma J, Tjoa CW, Puli SR, Bakshi R. A semiautomated measure of whole-brain atrophy in multiple sclerosis. J Neurol Sci 2003;208:57-65. (Pubitemid 36294155)
15. Bagnato F, JeffriesN, Richert ND, Stone RD, Ohayon JM, McFarland HF, et al. Evolution of T1 black holes in patients with multiple sclerosis imaged monthly for 4 years. Brain 2003;126:1782-9. (Pubitemid 36917337)
16. Cutter GR, Baier ML, Rudick RA, Cookfair DL, Fischer JS, Petkau J, et al. Development of a multiple sclerosis functional composite as a clinical trial outcome measure. Brain 1999;122:871-82. (Pubitemid 29219261)
17. Bermel RA, Bakshi R. The measurement and clinical relevance of brain atrophy in multiple sclerosis. Lancet Neurol 2006;5:158-70. (Pubitemid 43107851)
18. Neema M, Stankiewicz J, Arora A, Guss ZD, Bakshi R. MRI in multiple sclerosis: what's inside the toolbox? Neurotherapeutics 2007;4:602-17. (Pubitemid 47505349)
19. Bakshi R, Thompson AJ, Rocca MA, Pelletier D, Dousset V, Barkhof F, et al. MRI in multiple sclerosis: current status and future prospects. Lancet Neurol 2008;7:615-25.
20. Miki Y, Grossman R, Udupa JK, Wei L, Polansky M, Mannon LJ, et al. Relapsing-remitting multiple sclerosis: longitudinal analysis of MR images - lack of correlation between changes in T2 lesion volume and clinical findings. Radiology 1999;213:395-9. (Pubitemid 29510584)
21. Filippi M, Rocca MA, RovarisM. Clinical trials and clinical practice inmultiple sclerosis: conventional and emerging magnetic resonance imaging technologies. Curr Neurol Neurosci Rep 2002;2:267-76.
22. Pirko I, Lucchinetti CF, Sriram S, Bakshi R. Gray matter involvement in multiple sclerosis. Neurology 2007;68:634-64.
23. Horsfield MA, Sala S, Neema M, Absinta M, Bakshi A, Sormani MP, et al. Rapid semi-automatic segmentation of the spinal cord from magnetic resonance images: application in multiple sclerosis. Neuroimage 2010;50:446-55.